(Q33467258)

English

Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1 reference

Europe PubMed Central

Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

Battershill PE

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Clissold SP

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

publication date

1 November 1989

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

38

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

658-702

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Pancreatic islet cell tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of the effects of two somatostatin analogues in a patient with an external pancreatic fistula.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SMS 201-995, a somatostatin analogue, and diarrhea in the acquired immunodeficiency syndrome (AIDS)

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue symptomatic and peptide responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995 over 6 months.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of acromegaly with the long-acting somatostatin analog SMS 201-995

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor regression of an ileal carcinoid under the treatment with the somatostatin analogue SMS 201-995.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Administration of somatostatin analog (SMS 201-995) in the treatment of a fistula occurring after pancreas transplantation. Interference with cyclosporine immunosuppression

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of pancreatic cutaneous fistulas with a somatostatin analog.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-acting and selective suppression of growth hormone secretion by somatostatin analogue SMS 201-995 in acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of long acting somatostatin-analogue, SMS 201 995, on gut hormone secretion in normal subjects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Escape of the response to a long-acting somatostatin analogue (SMS 201-995) in patients with VIPoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of Intravenous Somatostatin and Vasopressin Infusions in Treatment of Acute Variceal Hemorrhage

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postprandial effects of SMS 201-995 on gut hormones and glucose tolerance

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemistry and pharmacology of SMS 201-995, a long-acting octapeptide analogue of somatostatin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin analogue SMS 201-995 long term therapy for vipoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term treatment of an infant with nesidioblastosis using a somatostatin analogue

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The response of serum growth hormone levels to the long-acting somatostatin analog SMS 201-995 in acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinicopathological study of pancreatic and ganglioneuroblastoma tumours secreting vasoactive intestinal polypeptide (vipomas).

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of SMS 201-995, a long-acting somatostatin analogue, on the secretion and morphology of a pituitary growth hormone cell adenoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Streptozocin Alone Compared with Streptozocin plus Fluorouracil in the Treatment of Advanced Islet-Cell Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of a somatostatin analogue SMS 201-995 on hepatic haemodynamics in the pig and on intravariceal pressure in man.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin analog treatment of acromegaly: new aspects

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of acromegaly with long acting somatostatin analogue SMS 201-995.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metastatic carcinoid tumors and the carcinoid syndrome. A selective review of chemotherapy and hormonal therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of somatostatin analogue (SMS 201-995) on molecular species of gastrin in gastrinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin and octreotide: literature review and description of therapeutic activity in pancreatic neoplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extrapancreatic, extraintestinal gastrinoma: effective treatment by surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of pituitary size by the somatostatin analogue SMS 201-995 in a patient with an islet cell tumour secreting growth hormone releasing factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral absorption of the somatostatin analogue SMS 201-995: theoretical and practical implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conservative treatment of external pancreatic fistulas with parenteral nutrition alone or in combination with continuous intravenous infusion of somatostatin, glucagon or calcitonin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of a somatostatin analogue in association with surgery and hepatic arterial embolisation in the treatment of the carcinoid syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of functional gastrointestinal endocrine tumors by endogenous and exogenous somatostatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The sensitivity of growth hormone and prolactin secretion to the somatostatin analogue SMS 201-995 in patients with prolactinomas and acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of a long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnosis and treatment of Zollinger-Ellison syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rebound hypergastrinemia after cessation of a somatostatin analogue (SMS 201-995) in malignant gastrinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conservative treatment of fistulas of the pancreas and the small intestine with somatostatin (author's transl)

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of metastasising GRF-producing tumour with a long-acting somatostatin analogue

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long term treatment of acromegaly with a long acting analogue of somatostatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heterogeneous forms of thyroid-stimulating hormone in mouse thyrotropic tumor and serum: differences in receptor-binding and adenylate cyclase-stimulating activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Octreotide: a synthetic analog of somatostatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Upper gastrointestinal bleeding: the trials of trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of a long-acting somatostatin analogue (SMS 201-995) on intermediary metabolism and gut hormones after a test meal in normal subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bleeding oesophageal varices

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effective long-term treatment of acromegaly with a long-acting somatostatin analogue (SMS 201-995).

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of two new antisecretory drugs on fluid and electrolyte transport in a patient with secretory diarrhoea

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin sensitivity and growth hormone responses to releasing hormones and bromocryptine in acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogue

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term management of acromegaly with sandostatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-pituitary actions of somatostatin. A review on the therapeutic role of SMS 201-995 (sandostatin).

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of postprandial hypotension with a somatostatin analogue (SMS 201-995).

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

On the use of a new somatostatin analogue in the treatment of hypoglycaemia in patients with insulinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medical treatment of acromegaly with SMS 201-995, a somatostatin analog: a comparison with bromocriptine

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic efficacy of a somatostatin analogue (SMS 201-995) in active acromegaly.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of severe cryptosporidium-related diarrhea with octreotide in a patient with AIDS

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-acting somatostatin analogue (Sandostatin) reduces late night insulinopenic ketogenesis in diabetic teenagers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Remission of symptoms of chemotherapy-refractory metastatic insulinoma using octreotide

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of somatostatin and vasopressin in the control of acute variceal hemorrhage

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of resistant acromegaly with a long-acting somatostatin analogue (SMS 201-995).

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ineffectiveness of SMS 201-995 in severe hyperinsulinemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful treatment of idiopathic secretory diarrhea of infancy with the somatostatin analogue SMS 201-995

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Homogeneity in the Growth Hormone–Lowering Effect of Dopamine and Somatostatin in Acromegaly*

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The spectrum of pituitary growth hormone responses to pharmacological stimuli in acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin treatment for cryptosporidial diarrhea in a patient with the acquired immunodeficiency syndrome (AIDS)

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of pancreatic fistula with the somatostatin analogue SMS 201-995.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and pathophysiological aspects of somatostatin and the gastrointestinal tract

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin and ranitidine in the control of iatrogenic haemorrhage of the upper gastrointestinal tract

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroendocrine tumours of the gut: long-term therapy with the somatostatin analogue SMS 201-995.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995)

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The somatostatin analog SMS 201-995 induces long-acting inhibition of growth hormone secretion without rebound hypersecretion in acromegalic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pseudopancreatic cholera syndrome: effect of a synthetic somatostatin analogue, SMS 201-995

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pre-operative treatment of 5 acromegalics with a somatostatin analogue: endocrine and clinical observations

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blind evaluation of the effect of octreotide (SMS 201-995), a somatostatin analogue, on small-bowel fistula output

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Karnofsky memorial lecture. An odyssey in the land of small tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of a long-acting somatostatin analogue (SMS 201-995) on postprandial gastric emptying of 99mTc-tin colloid and mouth-to-caecum transit time in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The somatostatin analogue SMS 201-995 in acromegaly: prolonged, preferential suppression of growth hormone but not pancreatic hormones

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of SMS 201-995 on intermediary metabolism and endocrine status in normal and diabetic humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin octapeptide (SMS 201-995) in the medical treatment of acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid reversal of carcinoid crisis with a somatostatin analogue

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of relapsing bleeding peptic ulcers with the somatostatin analogue SMS 201 995 in a patient with Zollinger-Ellison syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of a long-acting somatostatin derivative SMS 201-995 (sandostatin) on glucose homeostasis in type I diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin analogue (SMS 201-995) in patients with gastrinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful treatment of a VIPoma by continuous subcutaneous infusion of somatostatin analogue (SMS 201-995)

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical diagnosis of the Zollinger-Ellison syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolonged treatment of Zollinger-Ellison syndrome by long-acting somatostatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Perioperative use of long-acting somatostatin analog (SMS 201-995) in patients with endocrine tumors of the gastroenteropancreatic axis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroendocrine tumors. A European view

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin in persistent gastrointestinal fistula treated by total parenteral nutrition

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gut endocrinology: clinical and therapeutic impact

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of somatostatin and SMS 201-995 on carbohydrate metabolism in normal man

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective randomised controlled clinical trial comparing somatostatin and vasopressin in controlling acute variceal haemorrhage

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of inappropriate secretion of thyrotropin with somatostatin analog SMS 201-995.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperthyroidism due to non-tumoural inappropriate TSH secretion. Effect of a long-acting somatostatin analogue (SMS 201-995).

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of hepatic arterial embolisation in the carcinoid syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Closure of a high-output external pancreatic fistula by SMS 201-995, a long-acting analogue of somatostatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin analogue SMS 201-995 in type I diabetes mellitus. Initial experience after repeated administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term treatment of refractory neonatal hypoglycemia with long-acting somatostatin analog

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-acting somatostatin (SMS 201-995) in the management of Zollinger-Ellison syndrome: evidence for sustained efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of the dumping syndrome with the somatostatin analogue SMS 201-995

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of pentagastrin-stimulated acid secretion after subcutaneous administration of a new somatostatin analogue

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocrine profile of a long-acting somatostatin derivative SMS 201-995. Study in normal volunteers following subcutaneous administration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid reversal of life-threatening hypoglycaemia with a somatostatin analogue (octreotide). A case report

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bromocriptine therapy for hyperthyroidism due to increased thyrotropin secretion

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lung carcinoid with Cushing's syndrome: control of serum ACTH and cortisol levels using SMS 201-995 (sandostatin)

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High Density of Somatostatin Receptors in Pituitary Tumors from Acromegalic Patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of a long acting somatostatin analogue in controlling life threatening ileostomy diarrhoea

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe upper gastrointestinal bleeding. Part III: guidelines for treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of SMS 201-995, a long-acting somatostatin analogue, on anterior pituitary function in healthy male volunteers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of malignant endocrine pancreatic tumors with a new long-acting somatostatin analogue, SMS 201-995.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of a somatostatin analog (SMS 201-995) in the glucagonoma syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long term treatment with the somatostatin analog SMS 201-995 in a patient with a thyrotropin- and growth hormone-secreting pituitary adenoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Normalization of glucose homeostasis by a long-acting somatostatin analog SMS 201-995 in a newborn with nesidioblastosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Visual improvement with SMS 201-995 in a patient with a thyrotropin-secreting pituitary adenoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hormone-producing gastrointestinal tumors contain a high density of somatostatin receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised double blind trial of somatostatin in the treatment of massive upper gastrointestinal haemorrhage

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucose tolerance during long term treatment with a somatostatin analogue.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of somatostatin on basal and glucose induced insulin release in five patients with hyperinsulinaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of a single administration of somatostatin analogue (SMS 201-995) on GH, TSH and insulin secretion in patients with acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute and long-term effects of SMS 201-995 in acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth hormone secretion dynamics in a patient with ectopic growth hormone-releasing factor production.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin and cimetidine in peptic-ulcer haemorrhage. A randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of somatostatin and a long-acting analogue, SMS 201-995, in acute bleeding due to peptic ulceration

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Small bowel fistulas treated with somatostatin: preliminary results

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and hormonal effects of a long-acting somatostatin analogue in pancreatic endocrine tumors and in carcinoid syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of somatostatin analogue SMS 201-995 in normal man

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term use of somatostatin analogue SMS 201-995 in the treatment of hypoglycaemia due to nesidioblastosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SOMATOSTATIN IN TREATMENT OF HAEMATEMESIS AND MELAENA

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carcinoid crisis during anesthesia: successful treatment with a somatostatin analogue.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SMS 201-995 induces a continuous decline in circulating growth hormone and somatomedin-C levels during therapy of acromegalic patients for over two years

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-acting somatostatin analog in refractory neonatal hypoglycemia: follow-up information

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of somatostatin and its analogs in the treatment of surgical disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical evaluation of SMS 201-995. Long-term treatment in gut neuroendocrine tumours, efficacy of oral administration, and possible use in non-tumoural inappropriate TSH hypersecretion

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of the somatostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Observations on the effect of a somatostatin analog in the Zollinger-Ellison syndrome: implications for the treatment of apudomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regression of liver metastases in patient with gastrin-secreting tumour treated with SMS 201-995

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Malignant insulinoma: effects of a somatostatin analog (compound 201-995) on serum glucose, growth, and gastro-entero-pancreatic hormones

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of malignant carcinoid tumors with human leukocyte interferon: long-term results

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin analog SMS 201-995 and insulin needs in insulin-dependent diabetic patients studied by means of an artificial pancreas

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Remission of symptoms during long term treatment of metastatic pancreatic endocrine tumours with long acting somatostatin analogue

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Visualization of somatostatin receptors and correlation with immunoreactive growth hormone and prolactin in human pituitary adenomas: evidence for different tumor subclasses

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Absorption of an aqueous solution of a new synthetic somatostatin analogue administered to man by gavage

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regression of metastatic vipoma with somatostatin analogue SMS 201-995

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pancreatic cholera syndrome: effect of a synthetic somatostatin analog on intestinal water and ion transport.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short-term management of nesidioblastosis using the somatostatin analogue SMS 201-995

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison among the growth hormone-lowering effects in acromegaly of the somatostatin analog SMS 201-995, bromocriptine, and the combination of both drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A guide to the clinical use of the somatostatin analogue SMS 201-995 (Sandostatin).

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin analogue (SMS 201-995) in the management of gastroenteropancreatic tumors and diarrhea syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thyrotrophin-producing pituitary adenomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of SMS 201-995 (somatostatin analogue) in insulinomas. Additional case report and literature review

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of a long-acting somatostatin analogue (SMS 201-995) in controlling a significant ileal output in a 5-year-old child

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fasting Hypoglycemia in Adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of SMS 201-995 in healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of the effect of levodopa and somatostatin on the plasma levels of growth hormone, insulin, glucagon and prolactin in acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inappropriate secretion of thyrotropin by the pituitary

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SMS 201-995 and variceal haemorrhage

1 reference

https://pubmed.ncbi.nlm.nih.gov/2689136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-198938050-00002

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33467258&oldid=2195390652"